Literature DB >> 31473741

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients with Diabetes: A Double-Blind Randomized Controlled Trial.

Maeve Lynch1,2, Anna Malara3, Irene Timoney4, Tomas Ahern5, Fatima Awdeh4, Cheryl Sweeney3, Marie Galligan3, Sebastian Venckens3, Genevieve Kelly4, Rosalind Hughes4, Donal O Apos Shea3,5, Peter Doran6, Brian Kirby4,3.   

Abstract

Entities:  

Keywords:  Gliclazide; Psoriasis; Sitagliptin; Type 2 diabetes mellitus

Year:  2019        PMID： 31473741     DOI： 10.1159/000502130

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  2 in total

1.  Inhibition of dipeptidyl-peptidase 4 induces upregulation of the late cornified envelope cluster in keratinocytes.

Authors:  Lei Bao; Jing Li; Bethany E Perez White; Payal M Patel; Kyle T Amber
Journal:  Arch Dermatol Res       Date:  2021-06-05       Impact factor: 3.033

2.  Impact of Comorbidities of Patients with Psoriasis on Phototherapy Responses.

Authors:  Belén Fatás-Lalana; Joaquín Cantón-Sandoval; Lola Rodríguez-Ruiz; Raúl Corbalán-Vélez; Teresa Martínez-Menchón; Ana B Pérez-Oliva; Victoriano Mulero
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.